H2020
ADAPT-SMART
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 34 months
- Total cost
- EUR 4,064,146
- EU contribution
- EUR 1,130,000
- Participants
- 31 from 10 countries
- Topic
- H2020_IMI2-2015-04-01
- Grant agreement
- 115890
Coordinated by Stichting Lygature (NLNetherlands).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Stichting Lygature | NLNetherlands | Coordinator | EUR 522,000 | PIC (1.00) |
| Amgen | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Federation Europeenne D'Associations et D'Industries Pharmaceutiques | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Forum des Patients Europeens | BEBelgium | Participant | EUR 78,000 | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Ucb Biopharma | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Shire International GmbH | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Bayer Pharma AG | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Boehringer Ingelheim Internationalgmbh | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | EUR 0 | PIC (1.00) |
| H. Lundbeck As | DKDenmark | Participant | EUR 0 | PIC (1.00) |
| Novo Nordisk A/S | DKDenmark | Participant | EUR 0 | PIC (1.00) |
| Eurordis - Rare Diseases Europe | FRFrance | Participant | EUR 78,000 | PIC (1.00) |
| Haute Autorite de Sante | FRFrance | Participant | EUR 28,000 | known name (0.95) |
| Institut de Recherches Internationales Servier | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Ipsen Innovation Sas | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Lysogene | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | EUR 0 | PIC (1.00) |
| AbbVie Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Astellas Pharma Europe Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| National Institute for Health and Care Excellence | GBUnited Kingdom | Participant | EUR 232,500 | known name (0.95) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 135,500 | PIC (1.00) |
| Agenzia Italiana del Farmaco | ITItaly | Participant | EUR 28,000 | known name (0.95) |
| The European Medicines Agency | NLNetherlands | Participant | EUR 0 | PIC (1.00) |
| Zorginstituut Nederland | NLNetherlands | Participant | EUR 28,000 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | EUR 0 | PIC (1.00) |
| Massachusetts Institute of Technology | USUnited States | Participant | EUR 0 | PIC (1.00) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 31 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.